Cargando…

A window-of-opportunity biomarker study of etodolac in resectable breast cancer

Observational data show that nonsteroidal anti-inflammatory drug (NSAID) use is associated with a lower rate of breast cancer. We evaluated the effect of etodolac, an FDA-approved NSAID reported to inhibit cyclooxygenase (COX) enzymes and the retinoid X receptor alpha (RXR), on rationally identified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwab, Richard B, Kato, Shumei, Crain, Brian, Pu, Minya, Messer, Karen, Weidner, Noel, Blair, Sarah L, Wallace, Anne M, Carson, Dennis A, Parker, Barbara A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618628/ https://www.ncbi.nlm.nih.gov/pubmed/26275572 http://dx.doi.org/10.1002/cam4.512

Ejemplares similares

Randomized Controlled Trial of Etodolac versus Combination of Etodolac and Eperisone in Patients of Knee Osteoarthritis
por: Kaur, Navjot, et al.
Publicado: (2013)

R-etodolac is a more potent Wnt signaling inhibitor than enantiomer, S-etodolac
por: Roberts, JoAnn S., et al.
Publicado: (2022)

Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors
por: Bao, Lei, et al.
Publicado: (2015)

Etodolac and the risk of acute pancreatitis
por: Liao, Kuan-Fu, et al.
Publicado: (2017)

Spectrophotometric determination of etodolac in pure form and pharmaceutical formulations
por: Gouda, Ayman A, et al.
Publicado: (2008)

Etodolac Containing Topical Niosomal Gel: Formulation Development and Evaluation
por: Shilakari Asthana, Gyati, et al.
Publicado: (2016)

Mutual Amide Prodrug of Etodolac-glucosamine: Synthesis, Characterization and Pharmacological Screening
por: Pandey, Preeti, et al.
Publicado: (2013)

Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial
por: Hüttner, Felix J, et al.
Publicado: (2020)

Pharmacokinetic and pharmacodynamic studies of etodolac loaded vesicular gels on rats by transdermal delivery
por: Madhavi, Nimmathota, et al.
Publicado: (2018)

Nanostructured Lipid Carriers Engineered as Topical Delivery of Etodolac: Optimization and Cytotoxicity Studies
por: Czajkowska-Kośnik, Anna, et al.
Publicado: (2021)

Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization
por: Özdemir, Samet, et al.
Publicado: (2023)

Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies
por: Salah, Salwa, et al.
Publicado: (2017)

Identification of Substituted Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands
por: Chan, Michael, et al.
Publicado: (2013)

Window of Opportunity
Publicado: (1996)

Comparison of [(99m)Tc]Tilmanocept and Filtered [(99m)Tc]Sulfur Colloid for Identification of SLNs in Breast Cancer Patients
por: Baker, Jennifer L., et al.
Publicado: (2014)

Analysis of chiral non-steroidal anti-inflammatory drugs flurbiprofen, ketoprofen and etodolac binding with HSA
por: Guo, Chang-Chuan, et al.
Publicado: (2011)

Preemptive use of etodolac on tooth sensitivity after in-office bleaching: a randomized clinical trial
por: Vaez, Savil Costa, et al.
Publicado: (2018)

Non-Antimicrobial Drugs: Etodolac as a Possible Antimicrobial or Adjuvant Agent Against ESKAPE Pathogens
por: Pereira, Sónia G., et al.
Publicado: (2018)

Non-Antimicrobial Drugs: Etodolac as a Possible Antimicrobial or Adjuvant Agent Against ESKAPE Pathogens
por: Pereira, Sónia G., et al.
Publicado: (2018)

Etodolac improves collagen induced rheumatoid arthritis in rats by inhibiting synovial inflammation, fibrosis and hyperplasia
por: Feng, Qin, et al.
Publicado: (2021)

Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study
por: Oliva, Marc, et al.
Publicado: (2021)

An extended window of opportunity for G-CSF treatment in cerebral ischemia
por: Schneider, Armin, et al.
Publicado: (2006)

Anodic Oxidation of Etodolac and its Linear Sweep, Square Wave and Differential Pulse Voltammetric Determination in Pharmaceuticals
por: Yilmaz, B., et al.
Publicado: (2015)

Partial loss of genes might open therapeutic window
por: Liu, Bo, et al.
Publicado: (2017)

The Effects of Etodolac, Nimesulid and Naproxen Sodium on the Frequency of Sister Chromatid Exchange after Enclused Third Molars Surgery
por: Köseoğlu, Banu Gürkan, et al.
Publicado: (2008)

In Vivo Bioavailability and Therapeutic Assessment of Host-Guest Inclusion Phenomena for the Hydrophobic Molecule Etodolac: Pharmacodynamic and Pharmacokinetic Evaluation
por: Sinha, Vivek Ranjan, et al.
Publicado: (2010)

The COX-2 Selective Blocker Etodolac Inhibits TNFα-Induced Apoptosis in Isolated Rabbit Articular Chondrocytes
por: Kumagai, Kousuke, et al.
Publicado: (2013)

Nanostructured Lipid Carriers (NLC)-Based Gel Formulations as Etodolac Delivery: From Gel Preparation to Permeation Study
por: Czajkowska-Kośnik, Anna, et al.
Publicado: (2022)

Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer Immunotherapy
por: Sato-Kaneko, Fumi, et al.
Publicado: (2018)

A Triple High Throughput Screening for Extracellular Vesicle Inducing Agents With Immunostimulatory Activity
por: Shukla, Nikunj M., et al.
Publicado: (2022)

Windows of opportunity for the peopling of the Americas
por: Lesnek, Alia J.
Publicado: (2023)

Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer
por: Schuler, Kevin M, et al.
Publicado: (2015)

Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model
por: Shankara Narayanan, Jayanth S, et al.
Publicado: (2023)

Commentary: Two-sample Mendelian randomization: opportunities and challenges
por: Lawlor, Debbie A
Publicado: (2016)

miR-152/TNS1 axis inhibits non-small cell lung cancer progression through Akt/mTOR/RhoA pathway
por: Duan, Jinjin, et al.
Publicado: (2021)

A new design for a chronological release profile of etodolac from coated bilayer tablets: In-vitro and in-vivo assessment
por: Georgy, Kirolos R., et al.
Publicado: (2018)

Cost-effectiveness of surveillance with CT colonography after resection of colorectal cancer
por: Kuntz, Karen M, et al.
Publicado: (2020)

Generation and Application of a Reporter Cell Line for the Quantitative Screen of Extracellular Vesicle Release
por: Shpigelman, Jonathan, et al.
Publicado: (2021)

Windows of opportunity for daily physical activity
por: Du, Marvin
Publicado: (2020)

A Window of Opportunity for Newborn Screening
por: Bailey Jr, Donald B.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ivci24fc5fe0hj13k1sabihg9b